Company logo

CANO - Cano Health, Inc.

NYSE -> Healthcare -> Medical Care Facilities
Miami, United States
Type: Equity

CANO price evolution
CANO
(in millions $) 30 Jul 2022 1 May 2022 31 Jan 2022 29 Oct 2021
Current assets
Cash $208.91
Short term investments
Net receivables $200.99 $191.72 $133.43 $223.64
Inventory $1.11 $1.78
Total current assets $287.3 $323.63 $317.24 $465.12
Long term investments
Property, plant & equipment $274.75 $247.78 $217.43 $64.16
Goodwill & intangible assets
Total noncurrent assets $1674.96
Total investments
Total assets $2141.41 $2171.76 $2143.54 $2140.08
Current liabilities
Accounts payable $76.65
Deferred revenue $1.81
Short long term debt
Total current liabilities $142.06 $158.66 $161.04 $139.57
Long term debt $917.81 $918.48 $918.78 $916.28
Total noncurrent liabilities $1142.5
Total debt
Total liabilities $1729.15 $1785.56 $1824.81 $1282.07
Shareholders' equity
Retained earnings -$83.43 -$78.1 -$78.76 -$52.55
Other shareholder equity $547.45
Total shareholder equity
(in millions $) 31 Jan 2022 30 Jan 2021 30 Jan 2020
Current assets
Cash $1.04
Short term investments
Net receivables $133.43 $67.35 $49.25
Inventory $1.11 $0.92 $0.65
Total current assets $317.24 $1.22 $82.88
Long term investments
Property, plant & equipment $217.43 $38.13 $19.15
Goodwill & intangible assets
Total noncurrent assets $690.31 $0.05
Total investments
Total assets $2143.54 $691.53 $0.05
Current liabilities
Accounts payable
Deferred revenue
Short long term debt
Total current liabilities $161.04 $2.18 $0.05
Long term debt $918.78 $459.2 $134.03
Total noncurrent liabilities $684.35
Total debt
Total liabilities $1824.81 $686.53 $0.05
Shareholders' equity
Retained earnings -$78.76 -$28.89 -$0.01
Other shareholder equity -$0.13 -$0.13
Total shareholder equity
(in millions $) 30 Jul 2022 1 May 2022 31 Jan 2022 29 Oct 2021
Revenue
Total revenue $689.37 $526.8
Cost of revenue
Gross Profit $526.8
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $720.42 $536.43
Operating income -$9.63
Income from continuing operations
EBIT
Income tax expense $0.81 $0.55
Interest expense $17.04 $16.02
Net income
Net income -$5.33 -$14.64
Income (for common shares)
(in millions $) 31 Jan 2022 30 Jan 2021 30 Jan 2020
Revenue
Total revenue $1609.37
Cost of revenue
Gross Profit
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $1744.56 $5.71
Operating income -$5.71
Income from continuing operations
EBIT
Income tax expense $0.01
Interest expense $31.63
Net income
Net income -$18.02 -$28.88
Income (for common shares)
(in millions $) 30 Jul 2022 1 May 2022 31 Jan 2022 29 Oct 2021
Net income -$46.4
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$91.5
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$29.27 -$13.46 -$1131.25 -$1116.03
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$3.88 $0.54 $1389.14 $1382.63
Effect of exchange rate
Change in cash and equivalents -$115.32 -$50.12 $129.36 $175.11
(in millions $) 31 Jan 2022 30 Jan 2021 30 Jan 2020
Net income -$28.88
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$1.15
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$1131.25 -$690
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $1389.14 $692.19
Effect of exchange rate
Change in cash and equivalents $129.36 $1.04
Fundamentals
Market cap $4.31B
Enterprise value N/A
Shares outstanding 482.56M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q 75.34%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 2.02
Quick ratio N/A